Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Valentín Ortiz-Maldonado
Development of a Novel Anti-Cd19 Chimeric Antigen Receptor for a Spanish Approved Clinical Trial: A Paradigm for an Affordable CAR T Cell Production at Academic Institutions
Molecular Therapy - Methods and Clinical Development
Molecular Medicine
Genetics
Molecular Biology
Is There a Role for Minimal Residual Disease Monitoring in the Management of Patients With Hairy-Cell Leukaemia?
British Journal of Haematology
Hematology
Related publications
Automated Manufacturing of CD20.19 Bi-Specific Chimeric Antigen Receptor T (CAR-T) Cells at an Academic Center for a Phase I Clinical Trial in Relapsed, Refractory NHL
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Third-Generation Anti-Cd19 Chimeric Antigen Receptor T-Cells Incorporating a TLR2 Domain for Relapsed or Refractory B-Cell Lymphoma: A Phase I Clinical Trial Protocol (ENABLE)
BMJ Open
Medicine
An Introduction to Chimeric Antigen Receptor (CAR) T Cell Immunotherapy for Human Cancer
American Journal of Hematology
Hematology
Cytokine Release Syndrome and Neurotoxicity After CD19 Chimeric Antigen Receptor-Modified (CAR-) T Cell Therapy
British Journal of Haematology
Hematology
Safety of Allogeneic Hematopoietic Cell Transplant in Adults After Cd19 Targeted Chimeric Antigen Receptor-Modified T-Cell (Car-T) Therapy
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Comprehensive Report of Anti-Cd19 Chimeric Antigen Receptor T-Cells (Car-T) Associated Non Relapse Mortality (Cart-Nrm) From Faers
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Novel BAFF-R CAR T-Cell Therapy for CD19 Antigen-Loss Relapsed B Cell Tumors
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Pcn301 - Health Technology Assessment for Chimeric Antigen Receptor (Car) T-Cell Therapies for Cancer
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Clinical Chimeric Antigen Receptor‐T Cell Therapy: A New and Promising Treatment Modality for Glioblastoma
Clinical and Translational Immunology
Allergy
Immunology
Nursing
